搜索筛选:
搜索耗时0.1457秒,为你在为你在102,285,761篇论文里面共找到 7 篇相符的论文内容
发布年度:
[会议论文] 作者：John Zhong Li,
来源：第十一届湘雅国际糖尿病免疫学论坛 年份：2016
The Non-Alcoholic fatty liver disease (NAFLD) is the liver manifestation and clinical feature of metabolic syndrome.NAFLD described the wild spectrum of liver damage,ranging from simple steatosis to n...
[会议论文] 作者：John Zhong Li,Helen.H Hobbs,Jonathan.C Cohen,
来源：第十三次中国生物物理学术大会 年份：2013
...
,New insight into inter-organ crosstalk contributing to the pathogenesis of nonalcoholic fatty liver
[期刊论文] 作者：Xu Zhang,Xuetao Ji,Qian Wang,John Zhong Li,
来源：蛋白质与细胞 年份：2018
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver dysfunction and a significant global health problem with substantial rise in...
[会议论文] 作者：Xiuyun Wang,Yongqiang Lei,lijuan Fan,Jiaojiao Feng,John Zhong Li,
来源：第十四次全国暨国际生物物理大会 年份：2015
...
PO300-Responders defined by Selena Sledai, Bilag and physicians global assessment of disease activit
[会议论文] 作者：Vibeke Strand,Bruce Crawford,Michelle Petri,Rosalind Ramsey-Goldman,Vivian Fernandez,John Zhong,William,
来源：The 8th International Congress on SLE(第八届国际红斑狼疮学术会议) 年份：2007
...
CS1202 Novel Combined Response Endpoint Shows that Belimumab (Fully Human Monoclonal Antibody to B-L
[会议论文] 作者：Richard Furie,Vibeke Strand,Vivian Fernandez,John Zhong,William Freimuth,Daniel Wallace,Jeffrey Lisse,
来源：The 8th International Congress on SLE(第八届国际红斑狼疮学术会议) 年份：2007
...
CS1202 Novel Combined Response Endpoint Shows that Belimumab (Fully Human Monoclonal Antibody to B-L
[会议论文] 作者：Richard Furie,Vibeke Strand,Vivian Fernandez,John Zhong,William Freimuth,Daniel Wallace,Jeffrey Lisse,
来源：The 8th International Congress on SLE(第八届国际红斑狼疮学术会议) 年份：2007
...
相关搜索：
